New Strong Sell Stocks for May 1st

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Amplify Energy AMPY is an oil and natural gas company which is engaged in the acquisition, development, exploration and production of oil and natural gas properties. The Zacks Consensus Estimate for its current year earnings has been revised 48.5% downward over the last 60 days.

AST SpaceMobile ASTS is building the world’s first and only global cellular broadband network in space, accessible directly by standard smartphones (4G-LTE/5G devices) for commercial and government use, leveraging its extensive Intellectual Property and patent portfolio. The Zacks Consensus Estimate for its current year earnings has been revised 12.1% downward over the last 60 days.

Boundless Bio, Inc. BOLD is a clinical stage oncology company which is interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. The Zacks Consensus Estimate for its current year earnings has been revised almost 6.3% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research